Skip to main content
SpringerLink
Log in

Brain dopamine receptors: 20 Years of progress

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

I present a brief overview of the contribution of Paul Greengard's laboratory to the field of dopamine receptor research. I show that the work on the biochemical pharmacology of dopamine receptors was part of the intellectual foundation for the division of dopamine receptors into two general pharmacological categories.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kebabian, J. W., and Greengard, P. 1971. Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission. Science 174:1346–1349.

    Google Scholar 

  2. Kebabian, J. W., Petzold, G. L., and Greengard, P. 1972. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”, Proc. Natl. Acad. Sci., USA 69:2145–2149.

    Google Scholar 

  3. Ouimet, C. C., Miller, P. E., Hemmings, H. C., Jr., Walaas, S. I., and Greengard, P. 1984. DARPP-32, a dopamine-and adenosine 3′∶5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4:111–124.

    Google Scholar 

  4. Hemmings, H. C., Jr., Greengard, P., Tung, H. Y., and Cohen, P. 1984. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310:503–505.

    Google Scholar 

  5. Clement-Cormier, Y. C., Kebabian, J. W., Petzold, G. L., and Greengard, P. 1974. Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc. Natl. Acad. Sci., USA 71:1113–1117.

    Google Scholar 

  6. Kebabian, J. W., Calne, D. B., and Kebabian, P. R. 1977. Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro. Commun. Psychopharmacol. 1:311–318.

    Google Scholar 

  7. Kebabian, J. W., and Calne, D. B. 1979. Multiple receptors for dopamine, Nature 277:93–96.

    Google Scholar 

  8. Nishikori, K., Noshiro, O., Sano, K., and Maeno, H. 1980. Characterization, solubilization, and separation of two distinct dopamine receptors in canine caudate nucleus. J. Biol. Chem. 255:10909–10915.

    Google Scholar 

  9. Grewe, C. W., Frey, E. A., Cote, T. E., and Kebabian, J. W. 1982, YM-09151-2: a potent antagonist for a peripheral D2-dopamine receptor. Eur. J. Pharmacol. 81:149–152.

    Google Scholar 

  10. Setler, P. E., Sarau, H. M., Zirkle, C. L., and Saunder, H. L. 1978. The central effects of a novel dopamine agonist. Eur. J. Pharmacol. 50:419–430.

    Google Scholar 

  11. Iorio, L. C., Barnett, A., Leitz, F. H., Houser, V. P., and Korduba, C. A. 1983. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226:462–468.

    Google Scholar 

  12. Trugman, J. M., Arnold, W. S., Touchet, N., and Wooten, G. F. 1989. D1 dopamine agonist effects assessed in vivo with [14C]2-deoxyglucose autoradiography. J. Pharmacol. Exp. Ther. 250:1156–1160.

    Google Scholar 

  13. Bedard, P. J., and Boucher, R. 1989. Effect of D1 receptor stimulation in normal and MPTP monkeys. Neurosci. Lett. 104:223–228.

    Google Scholar 

  14. Braun, A., Fabbrini, G., Mouradian, M. M., Serrati, C., Barone, P., and Chase, T. N. 1987. Selective D-1 dopamine receptor agonist treatment of Parkinson's disease. J. Neural. Transm. 68:41–50.

    Google Scholar 

  15. Nomoto, M., Jenner, P., and Marsden, C. D. 1988. The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset. Neurosci. Lett. 93:275–280.

    Google Scholar 

  16. Pifl, C., Reither, H., and Hornykiewicz, O. 1991. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum. Eur. J. Pharmacol. 202:273–276.

    Google Scholar 

  17. Lovenberg, T. W., Brewster, W. K., Mottola, D. M., Lee, R. C., Riggs, R. M., Nichols, D. E., Lewis, M. H., and Mailman, R. B. Dihydrexidein, a novel selective high potency full dopamine D-1 receptor agoinst. Eur. J. Pharmacol. 166:111–113.

  18. Taylor, J. R., Lawrence, M. S., Redmond, D. E., Jr., Elsworth, J. D., Roth, R. H., Nichols, D. E., and Mailman, R. B. 1991. Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. Eur. J. Pharmacol. 199:389–391.

    Google Scholar 

  19. DeNinno, M. P., Schoenleber, R., Asin, K. E., MacKenzie, R., and Kebabian, J. W. 1990. (1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist. J. Med. Chem. 33:2948–2950.

    Google Scholar 

  20. DeNinno, M. P., Schoenleber, R., Perner, R. J., Lijewski, L., Asin, K. E., Britton, D. R., MacKenzic, R., and Kebabian, J. W. 1991. Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6, dihydroxy-1H-2-benzopyrans-: characterization of an auxiliary binding region in the D1 receptor, J. Med. Chem. 34:2561–2569.

    Google Scholar 

  21. Deninno, M. P., Schoenleber, R. P., MacKenzie, R., Britton, D. R. and others. 1991. A68930: A potent agonist selective for the dopamine D1 receptor, Eur. J. Pharmacol. 199:209–217.

    Google Scholar 

  22. Kebabian, J. W., Britton, D. R., DeNinno, M. P., Perner, R., Smith, L., Jenner, P., Schoenleber, R., and Williams, M. 1991. A77636: A potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in MPTP-treated marmosets. Eur. J. Pharmacol., submitted.

  23. Dearry, A., Gingrich, J. A., Falardeau, P., Fremeau, R. T., Jr, Bates, M. D., and Caron, M. G. 1990. Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347:72–76.

    Google Scholar 

  24. Monsma, F. J., Jr., Mahan, L. C., McVittie, L. D., Gerfen, C. R., and Sibley, D. R. 1990. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci (USA) 87:6723–6727.

    Google Scholar 

  25. Sunahara, R. K., Niznik, H. B., Weiner, D. M., Stormann, T. M., Brann, M. R., Kennedy, J. L., Gelernter, J. E., Rozmahel, R., Yang, Y. L., Israel, Y. et al. 1990. Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347:80–83.

    Google Scholar 

  26. Zhou, Q. Y., Grandy, D. K., Thambi, L., Kushner, J. A., Van Tol, H. H., Cone, R., Pribnow, D., Salon, J., Bunzow, J. R., and Civelli, O. 1990. Cloning and expression of human and rat D1 dopamine receptors. Nature 347:76–80.

    Google Scholar 

  27. Weiner, D. M., Levey, A. I., Sunahara, R. K., Niznik, H. B., O'Dowd, B. F., Seeman, P., and Brann, M. R. 1991. D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci (USA) 88:1859–1863.

    Google Scholar 

  28. Sunahara, R. K., Guan, H. C., O'Dowd, B. F., Seeman, P., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Van Tol, H. H., and Niznik, H. B. 1991. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350:614–619.

    Google Scholar 

  29. Grandy, D. K., Zhang, Y. A., Bouvier, C., Zhou, Q. Y., Johnson, R. A., Allen, L., Buck, K., Bunzow, J. R., Salon, J., and Civelli, O. 1991. Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc. Natl. Acad. Sci. (USA) 88:9175–9179.

    Google Scholar 

  30. Tiberi, M., Jarvie, K. R., Silvia, C., Falardeau, P., Gingrich, J. A., Godinot, N., Bertrand, L., Yang-Feng, T. L., Fremeau, R. T. Jr., and Caron, M. G. 1991. Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc. Natl. Acad. Sci. (USA) 88:7491–7495.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Biochemical Inc., 1 Strathmore Road, 01760, Natick, MA

    John W. Kebabian

Authors
  1. John W. Kebabian
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Special issue dedicated to Dr. Paul Greengard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kebabian, J.W. Brain dopamine receptors: 20 Years of progress. Neurochem Res 18, 101–104 (1993). https://doi.org/10.1007/BF00966928

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00966928

Key Words

Search

Navigation